These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 24887798)

  • 1. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience.
    Reha JL; Lee S; Hofmann LJ
    Am Surg; 2014 Jun; 80(6):595-9. PubMed ID: 24887798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.
    Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C
    Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
    Boza C; Riquelme A; Ibañez L; Duarte I; Norero E; Viviani P; Soza A; Fernandez JI; Raddatz A; Guzman S; Arrese M
    Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients.
    Campos GM; Bambha K; Vittinghoff E; Rabl C; Posselt AM; Ciovica R; Tiwari U; Ferrel L; Pabst M; Bass NM; Merriman RB
    Hepatology; 2008 Jun; 47(6):1916-23. PubMed ID: 18433022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery.
    Harnois F; Msika S; Sabaté JM; Mechler C; Jouet P; Barge J; Coffin B
    Obes Surg; 2006 Feb; 16(2):183-8. PubMed ID: 16469221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.
    Beymer C; Kowdley KV; Larson A; Edmonson P; Dellinger EP; Flum DR
    Arch Surg; 2003 Nov; 138(11):1240-4. PubMed ID: 14609874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic predictors of nonalcoholic steatohepatitis in a population undergoing bariatric surgery.
    Chisholm J; Seki Y; Toouli J; Stahl J; Collins J; Kow L
    Surg Obes Relat Dis; 2012; 8(4):416-22. PubMed ID: 21865094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.
    Bedossa P; Poitou C; Veyrie N; Bouillot JL; Basdevant A; Paradis V; Tordjman J; Clement K
    Hepatology; 2012 Nov; 56(5):1751-9. PubMed ID: 22707395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic histology in obese patients undergoing bariatric surgery.
    Machado M; Marques-Vidal P; Cortez-Pinto H
    J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
    Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
    J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery.
    Udelsman BV; Corey KE; Lindvall C; Gee DW; Meireles OR; Hutter MM; Chang DC; Witkowski ER
    Surg Obes Relat Dis; 2019 Jun; 15(6):843-849. PubMed ID: 31014948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D; Boynton J; Lindor KD
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease.
    Machado MV; Gonçalves S; Carepa F; Coutinho J; Costa A; Cortez-Pinto H
    Liver Int; 2012 Feb; 32(2):241-8. PubMed ID: 22098270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.